ExodusPoint Capital Management LP Sells 839,247 Shares of Sotera Health (NASDAQ:SHC)

ExodusPoint Capital Management LP reduced its position in Sotera Health (NASDAQ:SHC - Free Report) by 38.5% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,338,819 shares of the company's stock after selling 839,247 shares during the quarter. ExodusPoint Capital Management LP owned about 0.47% of Sotera Health worth $18,315,000 at the end of the most recent quarter.

Several other hedge funds also recently bought and sold shares of the company. Blue Trust Inc. raised its position in Sotera Health by 164.3% during the fourth quarter. Blue Trust Inc. now owns 1,834 shares of the company's stock valued at $25,000 after purchasing an additional 1,140 shares in the last quarter. GAMMA Investing LLC increased its position in shares of Sotera Health by 37.5% during the 4th quarter. GAMMA Investing LLC now owns 4,109 shares of the company's stock valued at $56,000 after purchasing an additional 1,121 shares during the last quarter. PNC Financial Services Group Inc. lifted its position in Sotera Health by 39.4% in the 4th quarter. PNC Financial Services Group Inc. now owns 9,302 shares of the company's stock worth $127,000 after buying an additional 2,627 shares during the last quarter. Rangeley Capital LLC bought a new stake in Sotera Health in the 4th quarter worth approximately $192,000. Finally, Envestnet Portfolio Solutions Inc. boosted its stake in Sotera Health by 17.3% in the fourth quarter. Envestnet Portfolio Solutions Inc. now owns 15,839 shares of the company's stock worth $217,000 after buying an additional 2,340 shares in the last quarter. Hedge funds and other institutional investors own 91.03% of the company's stock.

Sotera Health Trading Up 15.5 %

Shares of Sotera Health stock traded up $1.52 during midday trading on Wednesday, reaching $11.32. 2,108,387 shares of the company's stock traded hands, compared to its average volume of 1,192,308. The stock has a 50 day moving average of $12.28 and a 200-day moving average of $13.61. Sotera Health has a 12 month low of $9.53 and a 12 month high of $17.08. The company has a market cap of $3.21 billion, a PE ratio of 45.28 and a beta of 1.88. The company has a debt-to-equity ratio of 4.91, a quick ratio of 2.61 and a current ratio of 2.88.

Analyst Ratings Changes

Separately, Barclays cut their price target on shares of Sotera Health from $17.00 to $16.00 and set an "overweight" rating for the company in a research report on Friday, February 28th. Two equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $16.00.

Sotera Health Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.